Market Insider

Midday movers: Tesla Motors, Macy's, Target & More

Pictured here is an older Tesla Model S. Tesla’s Model S P100D with Ludicrous mode will use the same basic Model S body, but will have 100 kW/h battery, the Ludicrous mode hardware and a different badge.
Source: Tesla Motors

Take a look at some of Tuesday's midday movers:

Tesla Motors - Shares of the electric car manufacturer surged after Morgan Stanley doubled its price target to $320 a share. The stock has risen 650 percent over the past 14 months.

InterMune - Shares surged after the company said its experimental lung disease drug yielded positive results in a late-stage trial.

BlackBerry - Shares rose after it unveiled a newer, cheaper touchscreen smartphone and a classic model with a keyboard. Blackberry CEO John Chen that he would sell his instant messaging unit for $19 billion if someone offered him that much for it.

Macy's - The department-store operator gained after reporting an 11 percent increase in fourth-quarter profit.

Target - Shares of the discount retailer edged higher after a House committee demanded copies of messages and documents showing when the company found out about a huge data breach late last year.

Visteon - The auto-parts maker edged higher after it reported a better-than-expected quarterly profit.

Office Depot - Shares sank after the office-supplies chain reported a net loss for the fourth quarter.

LinkedIn - The professional networking site gained after it launched a Chinese language version. Other internet stocks including Groupon,, Netflix and Google also rose.

T-Mobile US - The mobile provider fell after reporting a bigger quarterly net loss and projected increased capital spending this year.

BioCryst Pharmaceuticals - Shares rose after the Food and Drug Administration accepted the new drug application for the company's Peramivir product.

Bristol-Myers Squibb - Shares edged lower after the company said the FDA had approved its drug for rare disorders involving loss of body fat.

(

—By CNBC's Rich Fisherman.

Questions? Comments? Email us at